Biotech and medtech are evolving at an unprecedented pace, and at the heart of this transformation is a growing need for professionals who can bridge science and strategy, innovation and impact. The Advanced Master in Biotech and MedTech Ventures (AMBT), offered by Solvay Lifelong Learning, is one of the few programmes in Europe that truly prepares future leaders to navigate this complexity and thrive in a fast-moving, purpose-driven sector.
So what makes this programme stand out? Here are ten reasons AMBT has become a launchpad for high-impact careers in life sciences and healthcare innovation.
At a time when scientific knowledge alone is not enough to lead healthcare ventures, AMBT provides an interdisciplinary experience at the crossroads of entrepreneurship, biotechnology, medtech, and strategic management. This rare combination gives students the fluency to move between labs, boardrooms, and investment meetings.
Whether you’re looking to launch your own venture, join a medtech startup, or support innovation from within a corporate or investment environment, AMBT is tailored for aspiring founders, intrapreneurs, and investors who want to shape what comes next in life sciences.
The programme is unapologetically practical. From investment simulations to startup projects and real company collaborations, students apply their knowledge in real-world scenarios from day one, gaining skills they can immediately use in the field.
Courses are delivered by a carefully selected mix of founders, venture capitalists, legal experts, business angels, and academics with deep sector expertise. This ensures that participants hear directly from those shaping the biotech and med-tech landscape in Europe and beyond.
Located in Brussels, AMBT gives participants privileged access to Belgium’s thriving biotech cluster — one of the most advanced in the world. The programme connects students to incubators, accelerators, investment funds, and policymakers at the European level.
From idea to implementation, students are immersed in every phase of the healthcare innovation journey. The curriculum covers key topics like IP, clinical trials, regulatory frameworks, reimbursement strategies, and fundraising, ensuring a complete understanding of what it takes to bring a solution to market.
With an estimated 90% of alumni employed shortly after or even before graduation, AMBT equips its students with a strong edge in an industry known for its rapid growth and constant innovation. Career paths range from entrepreneurship and venture capital to strategy consulting, business development, and leadership roles in healthtech.
The programme is particularly well-suited for bioengineers, scientists, clinicians, and regulatory or finance professionals who want to transition into strategic and leadership roles within the innovation-driven world of biotech and medtech startups.
AMBT alumni are more than just graduates; they remain part of a close-knit, international network of biotechnology and medtech professionals. Many mentor new cohorts, open career doors, and co-develop projects, reinforcing the programme’s community and impact.
The programme encourages ventures that improve human health and address ethical, environmental, and societal challenges in medical innovation. AMBT empowers founders who want to make a difference, not just in business but in the world.
If you're ready to move from potential to impact in biotech or medtech, this programme may be your next step. Explore the Advanced Master in Biotech and Medtech Ventures and discover how you can become part of Europe’s next wave of healthcare innovators.